Detalhe da pesquisa
1.
Nuclear tyrosine kinases: from Abl to WEE1.
Curr Opin Cell Biol
; 8(2): 174-81, 1996 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-8791414
2.
Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family.
Science
; 266(5182): 129-33, 1994 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-7939633
3.
Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.
Science
; 247(4946): 1079-82, 1990 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-2408149
4.
Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL).
Science
; 239(4841 Pt 1): 775-7, 1988 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-3422516
5.
Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway.
Curr Biol
; 11(22): 1759-65, 2001 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-11719217
6.
The Abl interactor proteins localize to sites of actin polymerization at the tips of lamellipodia and filopodia.
Curr Biol
; 11(11): 891-5, 2001 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-11516653
7.
Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis.
Mol Cell Biol
; 15(10): 5531-41, 1995 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-7565705
8.
Normal cellular and transformation-associated abl proteins share common sites for protein kinase C phosphorylation.
Mol Cell Biol
; 7(12): 4280-9, 1987 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-3125421
9.
SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence.
Mol Cell Biol
; 13(3): 1728-36, 1993 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-8441409
10.
Oncogenic activation of c-ABL by mutation within its last exon.
Mol Cell Biol
; 13(8): 4967-75, 1993 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-8336729
11.
A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction.
Mol Cell Biol
; 12(11): 5087-93, 1992 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-1383690
12.
BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.
Mol Cell Biol
; 11(4): 1785-92, 1991 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-2005881
13.
The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells.
Oncogene
; 15(19): 2333-42, 1997 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-9393877
14.
The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway.
Oncogene
; 13(12): 2589-94, 1996 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-9000132
15.
The 5' non-coding region of the BCR/ABL oncogene augments its ability to stimulate the growth of immature lymphoid cells.
Oncogene
; 6(8): 1299-306, 1991 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-1886706
16.
P150c-abl is detected in mouse male germ cells by an in vitro kinase assay and is associated with stage-specific phosphoproteins in haploid cells.
Oncogene
; 4(6): 685-90, 1989 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-2660070
17.
Baculovirus expression of functional P210 BCR-ABL oncogene product.
Oncogene
; 4(6): 759-66, 1989 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-2499863
18.
Identification of three protein kinases which phosphorylate threonyl-tRNA synthetase from rat liver.
FEBS Lett
; 206(2): 335-8, 1986 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-3019777
19.
Regulation of protein synthesis by phosphorylation of ribosomal protein S6 and aminoacyl-tRNA synthetases.
Prog Nucleic Acid Res Mol Biol
; 33: 195-230, 1986.
Artigo
em Inglês
| MEDLINE | ID: mdl-3541042
20.
Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity.
Genes Dev
; 9(21): 2569-82, 1995 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7590236